41297 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 31
14:18 UTC
|
BR
Broadridge Financial Solutions
|
◎ Target | Daniel R. Perlin not yet tracked | Outperform | $225.00→ $226.00+0.4% |
|
Aug 31
13:18 UTC
|
WELL
Welltower
|
◎ Target | Richard Hightower ★★★★☆ #384 | Equal Weight | $254.00→ $259.00+2.0% |
|
Aug 31
13:18 UTC
|
WAY
Waystar
|
◎ Target | Richard Close ★★★★☆ #523 | Buy | $30.00→ $33.00+10.0% |
|
Aug 31
13:18 UTC
|
VTR
Ventas
|
◎ Target | Richard Hightower ★★★★☆ #384 | Equal Weight | $99.00→ $102.00+3.0% |
|
Aug 31
13:18 UTC
|
VIK
Viking
|
◎ Target | Brandt Montour ★★★★☆ #774 | Equal Weight | $93.00→ $90.00-3.2% |
|
Aug 31
13:18 UTC
|
SBRA
Sabra Healthcare REIT
|
◎ Target | Richard Hightower ★★★★☆ #384 | Equal Weight | $21.00→ $23.00+9.5% |
|
Aug 31
13:18 UTC
|
RMD
ResMed
|
◎ Target | Brett Fishbin ★★★☆☆ #1592 | Overweight | $255.00→ $267.00+4.7% |
|
Aug 31
13:18 UTC
|
PATH
UiPath
|
◎ Target | Radi Sultan ★★★★☆ #468 | Neutral | $12.00→ $19.00+58.3% |
|
Aug 31
13:18 UTC
|
OHI
Omega Healthcare Investors
|
◎ Target | Richard Hightower ★★★★☆ #384 | Underweight | $51.00→ $50.00-2.0% |
|
Aug 31
13:18 UTC
|
MDB
MongoDB
|
◎ Target | firm only | Buy | $415.00→ $460.00+10.8% |
|
Aug 31
13:18 UTC
|
KYMR
Kymera Therapeutics
|
◎ Target | Brad Canino not yet tracked | Buy | $135.00→ $170.00+25.9% |
|
Aug 31
13:18 UTC
|
JAN
JAN
|
◎ Target | Richard Hightower ★★★★☆ #384 | Overweight | $33.00→ $34.00+3.0% |
|
Aug 31
13:18 UTC
|
GTLB
GitLab
|
◎ Target | Lucky Schreiner ★★★★☆ #691 | Neutral | $35.00→ $45.00+28.6% |
|
Aug 31
13:18 UTC
|
EMR
Emerson Electric
|
◎ Target | firm only | Outperform | $190.00→ $185.00-2.6% |
|
Aug 31
13:18 UTC
|
DOC
Healthpeak Properties
|
◎ Target | Richard Hightower ★★★★☆ #384 | Equal Weight | $23.00→ $24.00+4.3% |
|
Aug 31
13:18 UTC
|
CRM
Salesforce
|
◎ Target | Joseph Bonner ★★★☆☆ #2072 | Buy | $290.00→ $300.00+3.4% |
|
Aug 31
13:18 UTC
|
BRCC
BRC
|
◎ Target | Michael Baker ★★★★★ #177 | Buy | $2.50→ $25.00+900.0% |
|
Aug 31
13:18 UTC
|
BPOP
Popular
|
◎ Target | Brett Rabatin ★★☆☆☆ #2415 | Buy | $214.00→ $216.00+0.9% |
|
Aug 31
13:18 UTC
|
BNTX
BioNTech
|
◎ Target | John Newman ★★★☆☆ #1509 | Buy | $142.00→ $136.00-4.2% |
|
Aug 31
13:18 UTC
|
AHR
American Healthcare REIT
|
◎ Target | Richard Hightower ★★★★☆ #384 | Overweight | $61.00→ $66.00+8.2% |
|
Aug 31
13:18 UTC
|
ABNB
Airbnb
|
◎ Target | Tom White ★★★★☆ #762 | Buy | $175.00→ $220.00+25.7% |
|
Aug 31
12:18 UTC
|
SNOW
Snowflake
|
◎ Target | Thomas Blakey ★★★☆☆ #1027 | Overweight | $282.00→ $405.00+43.6% |
|
Aug 31
12:18 UTC
|
SBRA
Sabra Healthcare REIT
|
◎ Target | Vikram Malhotra ★★★☆☆ #1821 | Neutral | $20.00→ $21.00+5.0% |
|
Aug 31
12:18 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Ami Fadia ★★★★☆ #882 | Buy | $240.00→ $275.00+14.6% |
|
Aug 31
12:18 UTC
|
OHI
Omega Healthcare Investors
|
◎ Target | Haendel St. Juste ★★★★★ #184 | Neutral | $45.00→ $46.00+2.2% |
|
Aug 31
12:18 UTC
|
MPLT
Maplight Therapeutics
|
◎ Target | Ami Fadia ★★★★☆ #882 | Buy | $45.00→ $43.00-4.4% |
|
Aug 31
12:18 UTC
|
MDB
MongoDB
|
◎ Target | Thomas Blakey ★★★☆☆ #1027 | Overweight | $416.00→ $540.00+29.8% |
|
Aug 31
12:18 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Wamsi Mohan ★★★☆☆ #1524 | Buy | $80.00→ $82.00+2.5% |
|
Aug 31
12:18 UTC
|
GWRE
Guidewire Software
|
◎ Target | Joe Vruwink not yet tracked | Outperform | $202.00→ $235.00+16.3% |
|
Aug 31
12:18 UTC
|
GTLB
GitLab
|
◎ Target | Jonathan Ruykhaver ★★★★★ #263 | Neutral | $35.00→ $50.00+42.9% |
|
Aug 31
12:18 UTC
|
GTLB
GitLab
|
◎ Target | Nick Altmann ★★★★☆ #962 | Buy | $36.00→ $52.00+44.4% |
|
Aug 31
12:18 UTC
|
DELL
Dell Technologies
|
◎ Target | Wamsi Mohan ★★★☆☆ #1524 | Buy | $500.00→ $505.00+1.0% |
|
Aug 31
12:18 UTC
|
BWAY
Brainsway
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $17.00→ $19.00+11.8% |
|
Aug 31
12:18 UTC
|
ANDG
Andersen Group
|
◎ Target | Mark Marcon ★★★☆☆ #1130 | Outperform | $57.00→ $64.00+12.3% |
|
Aug 31
00:17 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | Outperform | C$190.00→ C$196.00+3.2% |
|
Aug 31
00:17 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Outperform | C$318.00→ C$321.00+0.9% |
|
Aug 30
19:16 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | Outperform | C$190.00→ C$196.00+3.2% |
|
Aug 30
19:16 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Outperform | C$318.00→ C$321.00+0.9% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Rishi Jaluria ★★★★☆ #509 | Outperform | $220.00→ $240.00+9.1% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Raimo Lenschow ★★★★★ #239 | Overweight | $200.00→ $224.00+12.0% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Brad Reback ★★★★☆ #767 | Hold | $115.00→ $160.00+39.1% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Mark Moerdler ★★☆☆☆ #2412 | Outperform | $216.00→ $238.00+10.2% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Michael Turrin ★★★☆☆ #1240 | Overweight | $215.00→ $225.00+4.7% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Keith Weiss ★★★☆☆ #1209 | Underweight | $145.00→ $180.00+24.1% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Steven Enders not yet tracked | Neutral | $139.00→ $201.00+44.6% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Matthew VanVliet ★★★★☆ #705 | Overweight | $220.00→ $205.00-6.8% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Jason Celino ★★★★☆ #477 | Overweight | $158.00→ $215.00+36.1% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Daniel Jester ★★★★☆ #475 | Outperform | $182.00→ $230.00+26.4% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | firm only | Buy | $202.00→ $218.00+7.9% |
|
Aug 30
00:14 UTC
|
WDAY
Workday
|
◎ Target | Billy Fitzsimmons ★★★★★ #217 | Neutral | $145.00→ $190.00+31.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.